Table 2.
Participant characteristics
| Study | Participants N (gender) |
Age (years) Mean (SD) |
BMI Mean (SD) |
Duration of diabetes (years) Mean (SD) |
HbA1C
Mean (SD) |
Baseline VO2max (mL/kg/min) Mean (SD) |
| Bally et al 23 | 12 (all M) | 26.2 (3.9) | 25.2 (3.4) | 14.2 (6.2) | 7 (0.6) | 47.9 (10.2) |
| Campbell et al 34 | 9 (7M/2F) | 35 (4.0) | 26.8 (1.1) | 25 (4) | 8.1 (0.2) | 41.8 (1.6) |
| Dubé et al 35 | 11 (5M/6F) | 26.5 (6.6) | 25.8 (2.7) | 12.2 (5.1) | 7.3 (0.4) | 33.4 (6.5) |
| Guelfi et al 16 | 7 (4M/3F) | 21.6 (4.0) | 24.7 (3.7) | 8.6 (5.0) | 7.4 (1.5) | 39.3 (7.4) |
| Hinojosa and Heiss30 | 7 (4M/3F) | 22.3 (4.3) | 25.4 (3.5) | 12.7 (3.5) | 7.4 (0.5) | NR |
| Iscoe and Riddell27 | 11 (5M/6F) | 35.1 (3.5) | NR | 15.6 (5.6) | 7.8 (0.4) | 42.4 (1.6) |
| Jankovec et al 24 | 12 (all M) | 33.4 (8.47) | 25.8 (3.67) | 16.4 (8.57) | 8.4 (0.95) | NR |
| Maran et al 25 | 8 (all M) | 34 (7) | 24 (2) | 14.3 (8) | 7.14 (0.6) | 33.7 (6.5) |
| Moser et al 28 | 7 (all M) | 24 (5.3) | 23.9 (2.5) | >1 years | 7.4 (0.6) | 52 (8.2) |
| Peter et al 31 | 13 (12M/1F) | 33.3 (6.5) | 26.8 (3.3) | ≥1 years | 7.6 (1.3) | NR |
| Rabasa-Lhoret et al 26 | 8 (all M) | 33 (8.8) | 23.4 (1.7) | 12.6 (8.8) | 6.1 (0.006) | 37.8 (3.5) |
| Soo et al 32 | 9 (8M/1F) | 25.8 (7.0) | 22.8 (1.2) | 7.3 (5.7) | NR | NR |
| Turner et al 37 | 8 (7M/1F) | 38 (6) | 26.9 (1.5) | 15 (4.5) | 8.7 (1.0) | NR |
| Yamanouchi et al 33 | 6 (3M/3F) | 42.7 (13.6) | 20.3 (2.3) | 5.6 (6.4) | 7.4 (0.9) | NR |
| Yardley et al 29 | 12 (10M/2F) | 31.8 (15.3) | 25.3 (3) | 12.5 (10) | 7.1 (1.1) | 51.2 (10.8) |
BMI, body mass index; F, female; HbA1C, glycosylated hemoglobin; M, male; NR, not recorded; VO2max, maximal oxygen uptake.